Diebold Nixdorf (DBD) Stock: Buy, Sell, or Hold?
DBD - Diebold Nixdorf, Incorporated
$63.18
1.96 (3.20%)
▲
5d:
+1.14%
30d:
-5.21%
90d:
-24.03%
HOLD
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When DBD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DBD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: DBD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$161.31
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$100.16
36.9% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DBD is currently trading at $63.18, which is considered slightly low relative to its 30-day fair value range of $62.71 to $67.66. From a valuation perspective, the stock is trading at a discount (Forward PE: 9.0) compared to its historical average (11.8). Remarkably, the market is currently pricing in an annual earnings decline of 8.7% over the next few years. This pessimistic expectation contrasts with the company's recent 34.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, DBD is in a strong downtrend. The price is approaching resistance at $65.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: DBD scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $98.33 (+55.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DBD is in a strong downtrend. The price is approaching resistance at $65.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: DBD scores 82/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. In the options market, Implied Volatility is low (17th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $98.33 (+55.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$62.71 -
$67.66
Company Quality Score
61/100
(BUY)
Options IV Signal
17th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
96.2%
Protect Your Profits
Holding DBD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 17th percentile)
- BULLISH: Strong technical setup (82/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 55.6% below Wall St target ($98.33)
- CAUTION: Bottoming setup, but lagging the sector by 19% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$62.71 -
$67.66
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$3.68
(5.8%)
Support & Resistance Levels
Support Level
$59.28
Resistance Level
$65.00
Current Trend
Strong Downtrend
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
9.00
Wall Street Target
$98.33
(+55.6%)
Revenue Growth (YoY)
1.7%
Earnings Growth (YoY)
34.2%
Profit Margin
2.9%
Valuation Discount vs History
-8.7% cheaper
PE vs Historical
9.0 vs 11.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.7%
(market-implied from PE analysis)
1-Year Target
$57.68
(-9%)
2-Year Target
$52.66
(-17%)
3-Year Target
$48.08
(-24%)
3-Yr Target (if PE normalizes)
(PE: 9→12)
$63.04
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 30.6%)
$319.34
(+405%)
Base:
(SPY PE: 9.0, Growth: 30.6%)
$140.89
(+123%)
Bear:
(PE: 7.6, Growth: 30.6%)
$119.75
(+90%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 20.27 | Current EPS (TTM): $3.02
Bull Case
$134.68
(+113%)
Analyst growth 100.0%, PE expands to 22.3
Base Case
$122.44
(+94%)
Market implied 100.0%, PE stable at 20.3
Bear Case
$41.63
(-34%)
Severe decline -20.0%, PE contracts to 17.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.0 to 11.8
Stabilization Target:
$82.84
(+31.1%)
PE Expansion Potential:
+31.1%
Share & Embed Analysis
Last updated: October 02, 2026 4:54 AM ET
Data refreshes hourly during market hours. Next update: 5:54 AM
Data refreshes hourly during market hours. Next update: 5:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DBD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Millstreet Capital Manag…
SELL
60833 shares
2026-04-16
Millstreet Capital Manag…
SELL
51472 shares
2026-04-15
Millstreet Capital Manag…
SELL
399929 shares
2026-04-08
Top Rated Software - Application Stocks
Top-rated stocks in Software - Application by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HUBS
HubSpot Inc |
STRONG BUY
36 analysts |
$250 | 63 BUY |
|
NOW
ServiceNow Inc |
STRONG BUY
47 analysts |
$145 | 59 HOLD |
|
ADSK
Autodesk Inc |
STRONG BUY
32 analysts |
$309 | 64 BUY |
|
GRAB
Grab Holdings Ltd |
STRONG BUY
27 analysts |
$6 | 52 HOLD |
|
ESTC
Elastic NV |
STRONG BUY
30 analysts |
$111 | 50 HOLD |
Advanced DBD Option Strategies
Professional options setups generated by AI based on today's DBD price and gamma walls.
